Cannabis; Adverse effects from an oromucosal spray

British Dental Journal

Volumn 203, Issue 6, 2007, Pages

  Scully, C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS; PLANT EXTRACT; TETRAHYDROCANNABINOL CANNABIDIOL COMBINATION; TETRAHYDROCANNABINOL-CANNABIDIOL COMBINATION; UNCLASSIFIED DRUG;

ADULT; AEROSOL; AGED; ARTICLE; CHEMICAL BURN; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; MOUTH MUCOSA; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PAIN; PHYTOTHERAPY;

ADMINISTRATION, ORAL; ADULT; AEROSOLS; AGED; BURNS, CHEMICAL; CANNABINOIDS; CANNABIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MULTIPLE SCLEROSIS; PAIN; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 34848869096     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/bdj.2007.749     Document Type: Article

References (28)

1. Newbury-Birch D, Lowry R J, Kamali F. The changing patterns of drinking, illicit drug use, stress, anxiety and depression in dental students in a UK dental school: a longitudinal study. Br Dent J 2002; 192: 646-649.
2. Gorter R W, Butorac M, Cobian E P, van der Sluis W. Medical use of cannabis in the Netherlands. Neurology 2005; 64: 917-919.
3. Ware M A, Adams H, Guy G W. The medicinal use of cannabis in the UK: results of a nationwide survey. Int J Clin Pract 2005; 59: 291-295.
4. Varma P. Public health issue brief: medical marijuana: year end report-2004. Issue Brief Health Policy Track Serv 2004; 31: 1-9.
5. Rog D J, Nurmikko T J, Friede T, Young C A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65: 812-819.
6. Blake D R, Robson P, Ho M, Jubb R W, McCabe C S. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) 2005; 45: 50-52.
7. Wright S, Ware M, Guy G. The use of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 781.
8. Perras C. Sativex for the management of multiple sclerosis symptoms. Issues Emerg Health Technol 2005; 72: 1-4.
9. Perez J. Combined cannabinoid therapy via an oromucosal spray. Drugs Today (Bare) 2006; 42: 495-503.
10. Barnes M P. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. Expert Opin Pharmacother 2006; 7: 607-615.
11. Berlach D M, Shir Y, Ware M A. Experience with the synthetic cannabinoid nabilone in chronic noncancer pain. Pain Med 2006; 7: 25-29.
12. Cole P, Rodu B, Mathisen A. Alcohol-containing mouthwash and oropharyngeal cancer: a review of the epidemiology. J Am Dent Assoc 2003; 134: 1079-1087.
13. Iversen L Long-term effects of exposure to cannabis. Curr Opin Pharmacol '2005; 5: 69-72.
14. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 849-863.
15. Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry 2005; 187: 510-515.
16. Hall W, Christie M, Currow D. Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol 2005; 6: 35-42.
17. Darling M R, Arendorf T M. Review of the effects of cannabis smoking on oral health. Int Dent J 1992; 42: 19-22.
18. Donald P J. Marijuana smoking - possible cause of head and neck carcinoma in young patients. Otolaryngol Head Neck Surg 1986; 94: 517-521.
19. Firth NA. Marijuana use and oral cancer: a review. Oral Oncol 1997; 33: 398-401.
20. Rosenblatt K A, Daling J R, Chen C, Sherman K J, Schwartz S M. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004; 64: 4049-4054.
21. Melamede R. Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J 2005; 2: 21.
22. Cho C M, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J 2005; 50: 70-74.
23. Darling M R, Arendorf T M. Effects of cannabis smoking on oral soft tissues. Community Dent Oral Epidemiol 1993; 21: 78-81.
24. Gregg J M, Campbell R L, Levin K J, Ghia J, Elliott R A. Cardiovascular effects of cannabinol during oral surgery. Anesth Analg 1976; 55: 203-213.
25. Horowitz L G, Nersasian R R. A review of marijuana in relation to stress-response mechanisms in the dental patient. J Am Dent Assoc 1978; 96: 983-986.
26. Pikkarainen P H, Baraona E, Jauhonen P, Seltz H K, Lieber C S. Contribution of oropharynx microflora and of lung microsomes to acetaldehyde in expired air after alcohol ingestion. J Lab Clin Med 1981; 97: 631-636.
27. Patton D W, Ferguson M M, Forsyth A, James J. Oro-facial granulomatosis: a possible allergic basis. Br J Oral Maxillofac Surg 1985; 23: 235-242.
28. Thavarajah R, Rao A, Raman U, Rajasekaran S T, Joshua E R H, Kannan R. Oral lesions of 500 habitual psychoactive substance users in Chennai, India. Arch Oral Biol 2006; 51: 512-519.